New monoclonal antibodies against B-cell antigens: Possible new strategies for diagnosis of primary cutaneous B-cell lymphomas

Immunology Letters

Volumn 134, Issue 2, 2011, Pages 157-160

  Fanoni, D ^a   Tavecchio, S ^a   Recalcati, S ^a   Balice, Y ^a   Venegoni, L ^a   Fiorani, R ^a   Crosti, C ^a   Berti, E ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Cutaneous B cell lymphoma; Human Leukocyte Differentiation Antigen Workshop; Monoclonal antibodies

Indexed keywords

B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD150 ANTIGEN; CD200 ANTIGEN; CD272 ANTIGEN; CD307A ANTIGEN; CD307B ANTIGEN; CD38 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; GLYCOPROTEIN GP 130; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 LIGAND 2; PROGRAMMED DEATH 1 RECEPTOR; SIGLEC 14 PROTEIN; SIGLEC 5 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY LABELING; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CELL TYPE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; MARGINAL ZONE LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; SKIN LYMPHOMA; TONSIL;

ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; PALATINE TONSIL; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650265250     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.09.022     Document Type: Article

References (7)

1. World health organization classification of tumors of haematopoietic and lymphoid tissues 2008, IARC Press, Lyon. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein (Eds.).
2. Pimpinelli N., Santucci M., Giannotti B. Cutaneous B-cell lymphomas: facts and open issues. J Eur Acad Dermatol Venereol 2004, 18:126-128.
3. Kerl H., Kodama K., Cerroni L. Diagnostic principles and new developments in primary cutaneous B-cell lymphomas. J Dermatol Sci 2004, 34:167-175.
4. Cattoretti G., Pileri S., Parravicini C., Becker M.H., Poggi S., Bifulco C., et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993, 171:83-98.
5. Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., MacDonald S., et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229.
6. Gualco G., Weiss L.M., Barber G.N., Bacchi C.E. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma. Hum Pathol 2010, 41:1238-1244.
7. Montes-Moreno S., Gonzalez-Medina A.R., Rodriguez-Pinilla S.M., Maestre L., Sanchez-Verde L., Roncador G., et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica 2010, 95:1342-1349.